Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China.

IF 5 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Wenqing Ni, Yuebin Lv, Xueli Yuan, Yan Zhang, Hongmin Zhang, Yijing Zheng, Xiaoming Shi, Jian Xu
{"title":"Associations of Low-density Lipoprotein Cholesterol With All-cause and Cause-specific Mortality in Older Adults in China.","authors":"Wenqing Ni, Yuebin Lv, Xueli Yuan, Yan Zhang, Hongmin Zhang, Yijing Zheng, Xiaoming Shi, Jian Xu","doi":"10.1210/clinem/dgae116","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Limited information was available on detailed associations of low-density lipoprotein cholesterol (LDL-C) with all-cause and cause-specific mortality in older adults.</p><p><strong>Methods: </strong>This prospective cohort study included a representative sample of 211 290 adults aged 65 or older who participated in Shenzhen Healthy Aging Research 2018-2019. The vital status of the participants by December 31, 2021, was determined. We estimated the hazard ratios (HR) with 95% confidence intervals for all-cause or cause-specific mortality using multivariable Cox proportional hazards models and Cox models with restricted cubic spline (RCS).</p><p><strong>Results: </strong>The median follow-up time was 3.08 years. A total of 5333 participants were confirmed to have died. Among them, 2037 cardiovascular disease (CVD) deaths and 1881 cancer deaths occurred. Compared to those with LDL-C of 100 to 129 mg/dL, the all-cause mortality risk was significantly higher for individuals with LDL-C levels that were very low (<70 mg/dL) or low (70-99 mg/dL). Compared with individuals with the reference LDL-C level, the multivariable-adjusted HR for CVD-specific mortality was 1.338 for those with very low LDL-C levels (< 70 mg/dL), 1.437 for those with high LDL-C levels (160 mg/dL ≤ LDL-C < 190 mg/dL), and 1.489 for those with very high LDL-C levels (≥190 mg/dL). Low LDL-C levels (70-99 mg/dL) and very low LDL-C levels (<70 mg/dL) were also associated with increased cancer mortality and other-cause mortality, respectively. The results from an RCS curve showed similar results.</p><p><strong>Conclusion: </strong>Considering the risk of all-cause mortality and cause-specific mortality, we recommended 100 to 159 mg/dL as the optimal range of LDL-C among older adults in China.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"e132-e139"},"PeriodicalIF":5.0000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae116","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Limited information was available on detailed associations of low-density lipoprotein cholesterol (LDL-C) with all-cause and cause-specific mortality in older adults.

Methods: This prospective cohort study included a representative sample of 211 290 adults aged 65 or older who participated in Shenzhen Healthy Aging Research 2018-2019. The vital status of the participants by December 31, 2021, was determined. We estimated the hazard ratios (HR) with 95% confidence intervals for all-cause or cause-specific mortality using multivariable Cox proportional hazards models and Cox models with restricted cubic spline (RCS).

Results: The median follow-up time was 3.08 years. A total of 5333 participants were confirmed to have died. Among them, 2037 cardiovascular disease (CVD) deaths and 1881 cancer deaths occurred. Compared to those with LDL-C of 100 to 129 mg/dL, the all-cause mortality risk was significantly higher for individuals with LDL-C levels that were very low (<70 mg/dL) or low (70-99 mg/dL). Compared with individuals with the reference LDL-C level, the multivariable-adjusted HR for CVD-specific mortality was 1.338 for those with very low LDL-C levels (< 70 mg/dL), 1.437 for those with high LDL-C levels (160 mg/dL ≤ LDL-C < 190 mg/dL), and 1.489 for those with very high LDL-C levels (≥190 mg/dL). Low LDL-C levels (70-99 mg/dL) and very low LDL-C levels (<70 mg/dL) were also associated with increased cancer mortality and other-cause mortality, respectively. The results from an RCS curve showed similar results.

Conclusion: Considering the risk of all-cause mortality and cause-specific mortality, we recommended 100 to 159 mg/dL as the optimal range of LDL-C among older adults in China.

中国老年人低密度脂蛋白胆固醇与全因和特定原因死亡率的关系。
背景:关于低密度脂蛋白胆固醇(LDL-C)与老年人全因死亡率和特定原因死亡率之间关系的详细资料十分有限:这项前瞻性队列研究纳入了 211,290 名 65 岁及以上成年人的代表性样本,他们都参与了 2018-2019 年深圳市健康老龄化研究。我们确定了参与者截至 2021 年 12 月 31 日的生命状态。我们使用多变量 Cox 比例危险模型和带受限立方样条(RCS)的 Cox 模型估算了全因或特因死亡率的危险比(HR)及 95% 的置信区间:中位随访时间为 3.08 年。共有 5333 名参与者确认死亡。其中,2,303人死于心血管疾病,1,881人死于癌症。与低密度脂蛋白胆固醇水平为 100-129 毫克/分升的人相比,低密度脂蛋白胆固醇水平很低(< 70 毫克/分升)或很低(70-99 毫克/分升)的人的全因死亡风险明显更高。与参考低密度脂蛋白胆固醇水平的个体相比,低密度脂蛋白胆固醇水平极低(< 70 毫克/分升)者的心血管疾病特异性死亡率经多变量调整后为 1.327,低密度脂蛋白胆固醇水平高(160 毫克/分升 ≦ 低密度脂蛋白胆固醇 < 190 毫克/分升)者为 1.437,低密度脂蛋白胆固醇水平极高(≥ 190 毫克/分升)者为 1.528。低密度脂蛋白胆固醇水平(70-99 毫克/分升)和极低密度脂蛋白胆固醇水平(< 70 毫克/分升)也分别与癌症死亡率和其他原因死亡率增加有关。RCS 曲线的结果显示了类似的结果:考虑到全因死亡率和特定病因死亡率的风险,我们建议将 100-159 mg/dL 作为中国老年人低密度脂蛋白胆固醇的最佳范围。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Endocrinology & Metabolism
Journal of Clinical Endocrinology & Metabolism 医学-内分泌学与代谢
CiteScore
11.40
自引率
5.20%
发文量
673
审稿时长
1 months
期刊介绍: The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信